drugset / Trial / NCT01636141

Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects

NCT01636141 ↗

Phase 1 Completed 36 enrolled Olatec Therapeutics, Inc.
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if OLT1177 Gel is safe and can be tolerated when given as a single dose and multidose to a defined area of one knee of healthy subjects.

Timeline

Start
2012-06
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dapansutrile Small molecule 3 % Topical
Comparator Dapansutrile Small molecule 5 % Topical

Indications

No indication recorded.